The discovery of rofecoxib, [MK 966, Vioxx®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor

被引：441

作者：

Prasit, P

Wang, Z

Brideau, C

Chan, CC

Charleson, S

Cromlish, W

Ethier, D

Evans, JF

Ford-Hutchinson, AW

Gauthier, JY

Gordon, R

Guay, J

Gresser, M

Kargman, S

Kennedy, B

Leblanc, Y

Léger, S

Mancini, J

O'Neill, GP

Ouellet, M

Percival, MD

Perrier, H

Riendeau, D

Rodger, I

Tagari, P

Thérien, M

Vickers, P

Wong, E

Xu, LJ

Young, RN

Zamboni, R

Boyce, S

Rupniak, N

Forrest, N

Visco, D

Patrick, D

机构：

[1] Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada

[2] Merck Res Labs, Harlow, Essex, England

[3] Merck Res Labs, Rahway, NJ 07065 USA

[4] Merck Res Labs, West Point, PA 19486 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 13期

关键词：

D O I：

10.1016/S0960-894X(99)00288-7

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The development of a COX-2 inhibitor rofecoxib (MK 966, Vioxx(R)) is described. It is essentially equipotent to indomethacin both in vitro and in vivo but without the ulcerogenic side effect due to COX-1 inhibition, (C) 1999 Published by Elsevier Science Ltd. All rights reserved.

引用

页码：1773 / 1778

页数：6

共 23 条

[1] A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors [J].

Brideau, C ;

Kargman, S ;

Liu, S ;

Dallob, AL ;

Ehrich, EW ;

Rodger, IW ;

Chan, CC .

INFLAMMATION RESEARCH, 1996, 45 (02) :68-74

[2]

CHAN CC, 1995, J PHARMACOL EXP THER, V274, P1531

[3]

CHAN CC, 1999, IN PRESS J PHARM EXP

[4]

DIKSHIT DK, 1990, INDIAN J CHEM B, V29, P954

[5]

EHRICH E, 1996, ARTHRITIS RHEUMATISM, V39

[6] Synthesis and biological evaluation of 2,3-diarylthiophenes as selective Cox-2 inhibitors .2. Replacing the heterocycle [J].

Gauthier, JY ;

Leblanc, Y ;

Black, WC ;

Chan, CC ;

Cromlish, WA ;

Gordon, R ;

Kennedey, BP ;

Lau, CK ;

Leger, S ;

Wang, ZY ;

Ethier, D ;

Guay, J ;

Mancini, J ;

Riendeau, D ;

Tagari, P ;

Vickers, P ;

Wong, E ;

Xu, LJ ;

Prasit, P .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (01) :87-92

[7] Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats [J].

GustafsonSvard, C ;

Lilja, I ;

Hallbook, O ;

Sjodahl, R .

GUT, 1996, 38 (01) :79-84

[8] Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells [J].

Kargman, S ;

Wong, E ;

Greig, GM ;

Falgueyret, JP ;

Cromlish, W ;

Ethier, D ;

Yergey, JA ;

Riendeau, D ;

Evans, JF ;

Kennedy, B ;

Tagari, P ;

Francis, DA ;

ONeill, GP .

BIOCHEMICAL PHARMACOLOGY, 1996, 52 (07) :1113-1125

[9]

KARGMAN SL, 1995, CANCER RES, V55, P2556

[10] SYNTHESIS AND BIOLOGICAL EVALUATION OF 2,3-DIARYLTHIOPHENES AS SELECTIVE COX-2 AND COX-1 INHIBITORS [J].

LEBLANC, Y ;

GAUTHIER, JY ;

ETHIER, D ;

GUAY, J ;

MANCINI, J ;

RIENDEAU, D ;

TAGARI, P ;

VICKERS, P ;

WONG, E ;

PRASIT, P .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (18) :2123-2128

← 1 2 3 →